Detail Infos Dara-H-Verumm: Dara Retreatment: Dara-PAN-Vd, Maintenance Therapy: Dara-PAN-V vs. Dara-V

Universitätsklinikum Freiburg ID: 543

• Entität Multiples Myelom
• Therapie-Linie R/R
• Altersgruppe ≥18
• Phase II
• Ein- / Auschlusskriterien - received Dara-Rd as relapse treatment in 2nd line - documented evidence of PD based on IMWG - prior Autologous SCT is allowed
• Arzt Prof. Dr. M. Engelhardt: (monika.engelhardt@uniklinik-freiburg.de)
• Study Nurse Rainer Lohmüller: Telefon 0761/270 32907; (rainer.lohmueller@uniklinik-freiburg.de)
• Link DRKS